about
Quantifying energy intake changes during obesity pharmacotherapy.Heritability of the weight loss response to gastric bypass surgery.Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery.Alterations in hypothalamic gene expression following Roux-en-Y gastric bypassWeight loss after gastric bypass is associated with a variant at 15q26.1.Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass.Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.Proportional Feedback Control of Energy Intake During Obesity Pharmacotherapy.
P2860
Q34270377-2B7E841C-9F72-41E6-A2FF-C7616F25169AQ35432935-8CE343EB-EF91-45BD-BADD-5A19A643A31EQ36069842-C87B3354-93F3-41EC-93A3-00D78EA0C677Q36740465-B84464F9-E394-4DFC-9B7C-5A7EEA635204Q36817373-336D56CA-0D82-40C6-9B96-01F1808EC40AQ37097880-6B953D36-3983-45C3-9B73-4E9C23431C64Q37862977-848F47BC-3060-4699-B162-89FADA685B44Q45947208-EEA94FC6-75C6-4E07-B1F4-DF298BAAD1BEQ47630248-C19214BA-16BC-47F8-9F53-BBD280897EEC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medications for weight reduction.
@en
Medications for weight reduction.
@nl
type
label
Medications for weight reduction.
@en
Medications for weight reduction.
@nl
prefLabel
Medications for weight reduction.
@en
Medications for weight reduction.
@nl
P1476
Medications for weight reduction.
@en
P304
P356
10.1016/J.ECL.2008.08.004
P577
2008-12-01T00:00:00Z